Hirbe AC - Search Results

1

A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy.

Hirbe AC, Jennings J, Saad N, Giardina JD, Tao Y, Luo J, Berry S, Toeniskoetter J, Van Tine BA. Hirbe AC, et al. Oncologist. 2018 Jul;23(7):760-e76. doi: 10.1634/theoncologist.2017-0536. Epub 2018 Feb 27. Oncologist. 2018. PMID: 29487221 Free PMC article. Clinical Trial.

2

Systemic delivery of murine SOD2 mRNA to experimental abdominal aortic aneurysm mitigates expansion and rupture.

Yan H, Hu Y, Lyu Y, Akk A, Hirbe AC, Wickline SA, Pan H, Roberson EDO, Pham CTN. Yan H, et al. Among authors: hirbe ac. bioRxiv [Preprint]. 2024 Jun 18:2024.06.17.599454. doi: 10.1101/2024.06.17.599454. bioRxiv. 2024. PMID: 38948794 Free PMC article. Preprint.

3

Novel pathways and molecular targets for the treatment of sarcoma.

Frith AE, Hirbe AC, Van Tine BA. Frith AE, et al. Among authors: hirbe ac. Curr Oncol Rep. 2013 Aug;15(4):378-85. doi: 10.1007/s11912-013-0319-3. Curr Oncol Rep. 2013. PMID: 23661264 Review.

4

BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. Hirbe AC, et al. Neuro Oncol. 2014 Mar;16(3):466-7. doi: 10.1093/neuonc/not248. Epub 2013 Dec 22. Neuro Oncol. 2014. PMID: 24366910 Free PMC article. No abstract available.

5

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors.

Hirbe AC, Cosper PF, Dahiya S, Van Tine BA. Hirbe AC, et al. Sarcoma. 2017;2017:3761292. doi: 10.1155/2017/3761292. Epub 2017 May 4. Sarcoma. 2017. PMID: 28546782 Free PMC article.

6

Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review.

Oppelt PJ, Hirbe AC, Van Tine BA. Oppelt PJ, et al. Among authors: hirbe ac. J Gastrointest Oncol. 2017 Jun;8(3):466-473. doi: 10.21037/jgo.2016.09.15. J Gastrointest Oncol. 2017. PMID: 28736634 Free PMC article. Review.

7

β-III-spectrin immunohistochemistry as a potential diagnostic tool with high sensitivity for malignant peripheral nerve sheath tumors.

Hirbe AC, Zhang X, Dahiya S, Godec A, Chrisinger J, Tao Y, Luo J, Gutmann DH. Hirbe AC, et al. Neuro Oncol. 2018 May 18;20(6):858-860. doi: 10.1093/neuonc/noy038. Neuro Oncol. 2018. PMID: 29596596 Free PMC article. No abstract available.

8

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.

Lu HC, Eulo V, Apicelli AJ, Pekmezci M, Tao Y, Luo J, Hirbe AC, Dahiya S. Lu HC, et al. Among authors: hirbe ac. Oncotarget. 2018 May 1;9(33):23018-23028. doi: 10.18632/oncotarget.25195. eCollection 2018 May 1. Oncotarget. 2018. PMID: 29796169 Free PMC article.

9

Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors.

Prudner BC, Rathore R, Robinson AM, Godec A, Chang SF, Hawkins WG, Hirbe AC, Van Tine BA. Prudner BC, et al. Among authors: hirbe ac. Clin Cancer Res. 2019 Aug 15;25(16):5122-5134. doi: 10.1158/1078-0432.CCR-19-0206. Epub 2019 May 21. Clin Cancer Res. 2019. PMID: 31113844 Free PMC article.

10

TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death.

Qin W, Godec A, Zhang X, Zhu C, Shao J, Tao Y, Bu X, Hirbe AC. Qin W, et al. Among authors: hirbe ac. Cancer Med. 2019 Sep;8(11):5232-5241. doi: 10.1002/cam4.2386. Epub 2019 Jul 6. Cancer Med. 2019. PMID: 31278855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters